Harness Critical Regulatory Insights, Achieve Scalable AI Implementation Whilst Mitigating Risks & Navigate A Volatile Geopolitical Landscape To Drive
Robust, Resilient, Transparent & Innovative
Risk & Compliance Strategies Across Pharmaceuticals & Life Sciences
4th Annual, Industry-Led Conference & Networking Exhibition | One America Square, London | 1st October 2026
08.30 Registration & Informal Networking
Opening Remarks
09.00 GIC Welcome & Morning Chair’s Opening Remarks
Kiki Merakli, VP, Chief Compliance Officer, Sobi
AI User Cases & Implementation
Opening Keynote
09.10 Achieve Effective AI Implementation & Master Regulatory Framework Development To Accelerate Organisation-Wide Adoption
- What are the current established uses of AI in compliance and what new trends are emerging? Deep-dive into the emerging best practices for AI adoption to enhance operations and efficiencies across the organisation
- Monitor the regulatory challenges around adopting new technologies and create coherent and comprehensive strategies for internal AI policies that enable effective implementation
- Keeping the human in the loop: from updated training techniques to promoting digital literacy across the workforce, how can responsible AI behaviours best be encouraged and monitored to ensure awareness of patient safety, data protection and bias mitigation?
- What lessons can be learned from AI implementation within the pharmaceuticals industry? Unpack the insights and troubleshooting from AI adoption to reframe your approaches in the future
Enrique Grande Jarque, Head of Ethics & Compliance Iberia, Takeda
Regulatory Updates & Trends
PANEL Q&A
09.35 Unpack Critical Emerging Regulatory Shifts, Stay Ahead Of The Curve & Unpack What’s Next For Compliance Professionals in 2026 & Beyond
- Drive the shift towards agile and risk-based regulatory frameworks to proactively tackle regulatory compliance developments and challenges
- Unpack the latest legislative and enforcement developments and translate regulatory change into clear and actionable priorities
- Analyse the potential impact of new and upcoming frameworks such as the EU AI Act and data protection policies to identify where scrutiny is intensifying and how professionals can proactively assess their controls and frameworks
- Look beyond immediate updates to assess long-term regulatory shifts to equip risk and compliance professionals with forward-looking strategies to remain agile and resilient in an increasingly complex global and regulatory landscape
Dr Corlia Van Der Walt, Director: R&D Partnerships & Legal Compliance, AstraZeneca
Alicia White, Director, PMCPA
